Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study. (2013). Journal of Analytical Oncology, 2(3),  128-134. https://doi.org/10.6000/1927-7229.2013.02.03.1